Tracy Finken Magnotta

Tracy Finken Magnotta is a Shareholder at the law firm of Anapol Weiss. For the past 24 years, her practice has been concentrated in the field of pharmaceutical and products liability, class actions and other complex civil litigation. She is currently investigating cases of women who used Depo-Provera and developed brain or spinal cord tumors (meningiomas) . Research has shown that Depo-Provera increases the risk of these types of tumors.

Tracy has been extensively involved in leadership roles in state and federal court in a variety of consolidated mass tort and multi-district litigations, including: Throughout her professional career, Tracy and her team have successfully achieved settlements for her clients totaling over $750 million dollars in a wide range of product liability and pharmaceutical liability matters. As a result, Tracy has been recognized annually for her outstanding legal work. From 2013 through 2026, she was named a Pennsylvania Super Lawyer. Tracy was also recognized as one of the Best Lawyers in America in the field of Plaintiffs' Mass Tort Litigation/Class Actions from 2016 through 2026.

This is the oldest and most respected peer-reviewed publication in the legal profession. Selection is based upon a rigorous peer-review survey completed by tens of thousands of leading attorneys. She also earned 2025 & 2026 Chambers Top Ranking for Litigation: Mainly Plaintiffs in addition to the National Trial Lawyers Top 100 in 2024-2026.